Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis’s big wager on RNAi approaches the finish line
EP Vantage
Wed, 11/25/20 - 10:27 am
Tags:
Novartis, RNAi, COVID-19, Leqvio, cholesterol
Novartis taps smartpatient for app to support wet AMD patients
Pharmaforum
Mon, 11/23/20 - 10:14 am
Tags:
Novartis, wet age-related macular degeneration, digital therapeutics, MyTherapy, mobile apps
Novartis Inks $1.35 Billion Deal with Mesoblast for Remestemcel-L for COVID-19 ARDS
BioSpace
Fri, 11/20/20 - 11:08 am
Tags:
Novartis, Mesoblast, remestemcel-L, COVID-19, ARDS, clinical trials
FDA begins review of Samsung Bioepis/Biogen’s Lucentis biosimilar
Pharmaforum
Thu, 11/19/20 - 10:33 am
Tags:
Novartis, Genentech, Lucentis, biosimilars, Samsung Bioepis, Biogen, FDA
Unmet Need in Dry Eye Disease Market Leaves Room for Other Drugmakers to Step In
BioSpace
Fri, 11/13/20 - 12:49 pm
Tags:
dry eye disease, Novartis, Allergan, Sun Pharma, Bausch, Kala Pharmaceuticals
Novartis’ Ilaris fails in late-stage COVID-19 trial
Pharmaforum
Fri, 11/6/20 - 09:59 am
Tags:
Novartis, Ilaris, COVID-19, clinical trials
Novartis’ Aimovig tops topiramate in migraine face-off
Pharmaforum
Wed, 11/4/20 - 10:20 am
Tags:
Novartis, Aimovig, Topiramate, migraines, clinical trials
Novartis adds new restriction to 340B discount policy
Beckers Hospital Review
Mon, 11/2/20 - 11:03 pm
Tags:
Novartis, 340B, hospitals
Novartis alums Jimenez, Fishman unveil their next act: Aditum Bio
Fierce Biotech
Mon, 11/2/20 - 10:18 am
Tags:
Joe Jimenez, Novartis, Aditum Bio, biotech, funding
Novartis sharpens focus on vision-restoring gene therapy with $150M Vedere buyout
Fierce Biotech
Thu, 10/29/20 - 11:59 am
Tags:
Novartis, Vedere Bio, gene therapy, vision loss
Novartis taps Molecular Partners for a new way to defeat COVID-19
Fierce Biotech
Wed, 10/28/20 - 10:33 am
Tags:
Novartis, Molecular Partners, antivirals, MP0420, MP0423, COVID-19
Novartis CEO thinks 2nd health lockdown unlikely, as Q3 sales stabilize
Pharmaforum
Tue, 10/27/20 - 10:36 am
Tags:
Novartis, earnings, COVID-19, pandemic
Novartis' Most Advanced Kidney Compound Shows Promise in C3G
BioSpace
Mon, 10/26/20 - 11:11 am
Tags:
Novartis, ASN, C3G, clinical trials, iptacopan
Novartis launches digital health hub in Canada
Pharmaforum
Fri, 10/23/20 - 10:51 am
Tags:
Novartis, Canada, innovation, digital health
Years after a major trial setback, Novartis switches gears with SMA drug. This time they're trying it for Huntington's
Endpoints
Wed, 10/21/20 - 11:43 pm
Tags:
Novartis, SMA, branaplam, Huntington's disease
Novartis bet $6B on the idea — now Versant, venBio have $45M to birth a platform play for radiopharmaceuticals
Endpoints
Wed, 10/14/20 - 10:51 am
Tags:
Versant Ventures, PSMA-617, radiopharmaceuticals, prostate cancer, Novartis, Rayze Bio, venBio
Pandemic speeds up Novartis’ transformation
MedCity News
Wed, 10/14/20 - 10:21 am
Tags:
Novartis, digital health, artificial intelligence, data, HLTH, pandemic, COVID-19
Novartis vets get $35M to pluck one of the pharma giant’s abandoned drugs off the shelf and put it back into a clinical trial
Endpoints
Mon, 10/12/20 - 10:10 am
Tags:
Novartis, KRP-203, Kyorin, Priothera Limited, AML
Pharmacquired: Splashy deals belie a shallow pool of heart drugs left to acquire
BioPharma Dive
Thu, 10/8/20 - 11:16 pm
Tags:
M&A, cardiology, Bristol-Myers Squibb, MyoKardia, Novartis, The Medicines Company
Occupied with immunology and cancer, Merck KGaA hands off osteoarthritis drug to Novartis for €50M cash
Endpoints
Tue, 10/6/20 - 11:26 pm
Tags:
Merck, KGaA, Novartis, sprifermin, osteoarthritis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.